-
D648313-100mgDNA31 is a potent RNA polymerase inhibitor.Form:Solid.
-
D648313-10mgDNA31 is a potent RNA polymerase inhibitor.Form:Solid.
-
D648313-25mgDNA31 is a potent RNA polymerase inhibitor.Form:Solid.
-
D648313-50mgDNA31 is a potent RNA polymerase inhibitor.Form:Solid.
-
D648313-5mgDNA31 is a potent RNA polymerase inhibitor.Form:Solid.
-
D650582-10mgDNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12). DNMDP shows clear cell-selective cytotoxicityIn VitroDNMDP
-
D650582-25mgDNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12). DNMDP shows clear cell-selective cytotoxicityIn VitroDNMDP
-
D650582-5mgDNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12). DNMDP shows clear cell-selective cytotoxicityIn VitroDNMDP
-
D656325-1mlDNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12). DNMDP shows clear cell-selective cytotoxicityIn VitroDNMDP
-
D651299-10mgDNMT3A-IN-1 is a potent and selective DNMT3A inhibitor. DNMT3A-IN-1 shows inhibitor activities against DNMT3A with k I values range from 9.16-18.85 μM (AdoMet) and 11.37-23.34 μM (poly dI-dC)Form:SolidIC50&: Target:DNMT3A.
-
D651299-5mgDNMT3A-IN-1 is a potent and selective DNMT3A inhibitor. DNMT3A-IN-1 shows inhibitor activities against DNMT3A with k I values range from 9.16-18.85 μM (AdoMet) and 11.37-23.34 μM (poly dI-dC)Form:SolidIC50&: Target:DNMT3A.
-
D655896-1mlDO-264 is a selective and in vivo-active inhibitor of Abhydrolase Domain Containing 12 ( ABHD12 ), with an IC 50 of 11 nM.In VitroDO-264 displays an IC 50 value of 11 nM (9.6 nM-13 nM). DO-264 blocks lyso-PS hydrolysis activities of recombinant